CHI3L1 and inflammatory bowel disease: In the active phase of IBD, CHI3L1 is continuously secreted as a 40 kDa protein from CECs and macrophages into the intestinal lumens, and therefore, it is reasonable that not only serum but also fecal CHI3L1 seems to be a reliable biomarker for predicting the severity and activity of IBD [72,73].